Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine and venlafaxine for chemotherapy-induced neuropathy in cancer patients
IRCT20240314061286N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in polyneuropathy and chemotherapy-induced peripheral neuropathy (CIPN) comparing Duloxetine arm, Venlafaxine arm and Placebo arm (3 arms). Started Mar 2024; status: completed.
02
Drugs
duloxetinevenlafaxine
03
Conditions
polyneuropathychemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on IRCT20240314061286N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240314061286N1.